Alnylam Pharmaceuticals, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US02043Q1076
USD
295.05
-0.86 (-0.29%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAlnylam Pharmaceuticals, Inc. VS Pharmaceuticals & Biotechnology
 
1D
-0.29%
0.84%
1W
-0.36%
2.33%
1M
-9.84%
9.08%
YTD
-25.8%
8.08%
1Y
14.21%
30.63%
3Y
40.53%
78.8%
5Y
124.71%
74.81%
10Y
431.14%
259.67%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-10.09%
0%
-10.09%
6 Months
-33.35%
0%
-33.35%
1 Year
14.21%
0%
14.21%
2 Years
93.74%
0%
93.74%
3 Years
40.53%
0%
40.53%
4 Years
118.96%
0%
118.96%
5 Years
124.71%
0%
124.71%

Alnylam Pharmaceuticals, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary